CVI Track the topics, authors and articles important to you
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 25 July 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00137-07v1
14/9/1235    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bubeck, S. S.
Right arrow Articles by Dube, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bubeck, S. S.
Right arrow Articles by Dube, P. H.
Clin. Vaccine Immunol. doi:10.1128/CVI.00137-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Yersinia pestis CO92{Delta}yopH is a potent live-attenuated plague vaccine

Sarah S. Bubeck and Peter H. Dube*

The University of Texas Health Science Center at San Antonio, Department of Microbiology and Immunology, 7703 Floyd Curl Dr., San Antonio, TX 78229

* To whom correspondence should be addressed. Email: dube{at}uthscsa.edu.


  Abstract

An in-frame deletion of the yopH gene in Yersinia pestis CO92 attenuates virulence in both bubonic and pneumonic plague models. When used as a live attenuated vaccine CO92{Delta}yopH provides a high degree of protection from parental and respiratory challenge with Y. pestis CO92.




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.